期刊文献+

卵巢癌细胞通过P38 MAPK通路促进CD8^+调节T细胞的生成 被引量:3

Ovarian cancer cells promote the generation of CD8^+ regulatory T cells through P38 MAPK signaling
下载PDF
导出
摘要 目的探讨丝裂原活化蛋白激酶(MAPK)信号通路在卵巢癌细胞(SKOV3)诱导CD8+Treg分化过程中的作用。方法建立SKOV3与健康人CD8+T细胞体外共培养体系,设置CD8+T细胞单独培养组为对照组。共培养5 d后,收集各组CD8+T细胞,荧光定量PCR和流式细胞术检测CD8+T细胞中Treg相关标志物(CD25、Foxp3、CD28)的表达率;功能抑制试验检测两组CD8+T细胞对nave CD4+T细胞增殖能力的影响;Western blot检测MAPK通路相关蛋白(ERK/p-ERK、JNK/p-JNK、P38 MAPK/p-P38 MAPK)的表达水平;P38 MAPK特异性抑制剂SB203580预处理CD8+T细胞后,评价CD8+T细胞中Treg相关标志物(CD25、Foxp3、CD28)的表达变化。结果共培养组CD8+T细胞中CD25及Foxp3表达率均显著高于对照组(P<0.05),CD28表达率显著低于对照组(P<0.05);共培养组CD8+T细胞相比对照组,抑制nave CD4+T细胞的增殖力增强;Western blot结果显示,共培养组p-P38 MAPK的表达水平显著高于对照组(P<0.05),SB203580预处理后CD8+T细胞中Treg相关标志物表达率均下调。结论卵巢癌细胞通过活化CD8+T细胞的P38 MAPK信号通路诱导具有抑制作用的CD8+Treg的生成,促进肿瘤进展。 Objective To investigate the effects of mitogen-activated protein kinase( MAPK) signaling pathway on the differentiation of CD8+regulatory T cells induced by ovarian cancer cell line SKOV3. Methods Coculture systerm of CD8+T cells and SKOV3 was conducted in vitro,CD8+T cells cultured alone group acted as control group. At day 5,CD8+T cells were collected,mRNA and protein expression level of CD28,CD25,Foxp3 in CD8+T cells were detected by real-time PCR and flow cytometry. Western blot was used to detect the expression of p-ERK,ERK,p-JNK,JNK,p-P38 MAPK and P38 MAPK. Proliferation assay was applied to analyze the effect of CD8+T cells on nave CD4+T cells. The phenotypic changes of CD8+T cells were determined after 4 hours pre-incubation with the specific inhibitors of P38 MAPK( SB203580). Results In co-cultured group the mRNA and protein expression of CD25 and Foxp3 were higher than those in the control group( P 〈 0. 05); and the expressionof CD28 was significantly lower than that in the control group( P 〈 0. 05); The expression of p-P38 MAPK in the co-cultured group was significant higher than that in the control group( P 〈 0. 05); After pre-incubated with SB203580 for 4 hours,the phenotypic of CD8+Tregs significantly decreased. Conclusions P38 MAP Kinase signaling is required for the generation of CD8+Tregs induced by ovarian cancer cell,which facilitates tumor growth.
出处 《基础医学与临床》 CSCD 2016年第2期167-172,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(81272324 81371894) 江苏省实验诊断学重点实验室基金(XK201114)
关键词 卵巢癌 CD8+T细胞 调节性T细胞 MAPK通路 ovarian cancer cell CD8+ T cell regulatory T cell MAPK patway
  • 相关文献

参考文献3

二级参考文献47

  • 1周涯,徐林,任社华,张明,汤贤英.肿瘤局部湿热治疗乳腺癌实验动物模型的建立及意义[J].中国医学物理学杂志,2007,24(4):271-274. 被引量:4
  • 2李健,黄赤兵,郑峻松,张艮甫,王琦,冯嘉瑜,肖亚,贾维胜,方针强.应用CD4^+CD25^+Treg细胞诱导大鼠肾移植免疫耐受的研究[J].重庆医学,2007,36(23):2396-2398. 被引量:4
  • 3Luvero D, Milani A, Ledermann JA. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. TherAdv Med Onco12014; 6: 229-239.
  • 4Zsiros E, Tanyi J, Balint K, Kandalaft LE. Immunotherapy for ovarian cancer: recent advances and perspectives. CurrOpin 0ncol2014; 26: 492-500.
  • 5Yigit R, Massuger LF, Figdor CG, Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Onco12010; 117: 366-372.
  • 6Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 2012; 72: 2162-2171.
  • 7Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ et al. Depletion of CD4+CD25+ regulatory T cells promotes a tumor- specific immune response in pancreas cancer-bearing mice. Ann Surg 0ncol2006; 13: 1252-1258.
  • 8Liu S, Foulkes WD, Leung S, Gao D, Lau S, Kos Z et al. Prognostic significance of FOXP3+ tumor infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration. Breast Cancer Res 2014; 16: 432..
  • 9Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Onco12009; 27: 186-192.
  • 10Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Research 2007; 13: 6947-6958.

共引文献17

同被引文献18

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部